Clinical Trials

Vapitadine in utricaria

Barrier Therapeutics announces positive results in reducing itch symptoms with novel oral antihistamine agent Hivenyl

 
to Continue Reading, Login Now
 

Please Login

 
 
  
 
 
If you are a registered user but you have forgotten your password, please click here
 
If you are not a registered user, please register here